JP2016528176A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016528176A5 JP2016528176A5 JP2016517683A JP2016517683A JP2016528176A5 JP 2016528176 A5 JP2016528176 A5 JP 2016528176A5 JP 2016517683 A JP2016517683 A JP 2016517683A JP 2016517683 A JP2016517683 A JP 2016517683A JP 2016528176 A5 JP2016528176 A5 JP 2016528176A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nucleic acid
- acid molecule
- hbcag
- copies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 claims 25
- 108090000623 proteins and genes Proteins 0.000 claims 25
- 102000039446 nucleic acids Human genes 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 10
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 238000000034 method Methods 0.000 claims 9
- 101710132601 Capsid protein Proteins 0.000 claims 8
- 239000002245 particle Substances 0.000 claims 8
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 5
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims 5
- 241001465754 Metazoa Species 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 102000006830 Luminescent Proteins Human genes 0.000 claims 1
- 108010047357 Luminescent Proteins Proteins 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 102000034287 fluorescent proteins Human genes 0.000 claims 1
- 108091006047 fluorescent proteins Proteins 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361831707P | 2013-06-06 | 2013-06-06 | |
| US61/831,707 | 2013-06-06 | ||
| PCT/GB2014/051739 WO2014195713A1 (en) | 2013-06-06 | 2014-06-05 | Single domain antibody display |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016528176A JP2016528176A (ja) | 2016-09-15 |
| JP2016528176A5 true JP2016528176A5 (cg-RX-API-DMAC7.html) | 2017-07-13 |
Family
ID=51022893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016517683A Pending JP2016528176A (ja) | 2013-06-06 | 2014-06-05 | シングルドメイン抗体ディスプレイ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160122420A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3004173B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2016528176A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105431457A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2914555A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014195713A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201402890D0 (en) | 2014-02-18 | 2014-04-02 | Iqur Ltd | Vaccines based on hepatitis B Core antigens |
| GB201421692D0 (en) * | 2014-12-05 | 2015-01-21 | Iquar Ltd | Vaccines based on hepatitis B core antigens |
| JP6871866B2 (ja) * | 2015-02-03 | 2021-05-19 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 抗ｒｈｏ ｇｔｐａｓｅコンホーメーションシングルドメイン抗体及びその使用 |
| BR112019009221A2 (pt) | 2016-11-11 | 2019-07-16 | Fraunhofer Usa Inc | proteína de fusão, método para produzir a proteína, composição, partícula semelhante a vírus, método para produzir partículas semelhantes a vírus, e método para induzir uma resposta imunológica em um sujeito |
| CN113138276B (zh) * | 2020-01-19 | 2022-09-16 | 厦门万泰凯瑞生物技术有限公司 | 用于检测HBcAg的方法及抗体 |
| CA3169031A1 (en) * | 2020-02-27 | 2021-09-02 | Trushar R. PATEL | Polypeptides directed against viral infection and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2200016T3 (es) | 1989-03-21 | 2004-03-01 | Vical Incorporated | Expresion de secuencias polinucleotidicas exogenas en un vertebrado. |
| US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
| US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| WO1993018759A1 (en) | 1992-03-20 | 1993-09-30 | Baylor College Of Medicine | A dna transporter system and method of use |
| ATE260679T1 (de) | 1992-04-03 | 2004-03-15 | Univ California | Selbstorganisierendes system zur verabreichung von polynukleotiden enthaltend ein amphiphatisches peptid |
| US5651981A (en) | 1994-03-29 | 1997-07-29 | Northwestern University | Cationic phospholipids for transfection |
| US5527928A (en) | 1994-09-30 | 1996-06-18 | Nantz; Michael H. | Cationic transport reagents |
| AP1836A (en) * | 2000-04-07 | 2008-03-14 | Univ Of Leeds Innovations Limited | Hepatitis b core antigen fusion proteins. |
| JP4791730B2 (ja) | 2002-09-27 | 2011-10-12 | パウダージェクト リサーチ リミテッド | 核酸コーティング粒子 |
| US20120015899A1 (en) * | 2008-10-25 | 2012-01-19 | Plant Bioscience, Limited | Modified plant virus particles and uses therefor |
| GB0918679D0 (en) * | 2009-10-23 | 2009-12-09 | Iqur Ltd | Influenza vaccine |
| WO2011116226A2 (en) * | 2010-03-17 | 2011-09-22 | Stc.Unm | Display of antibody fragments on virus-like particles of rna bacteriophages |
-
2014
- 2014-06-05 US US14/896,343 patent/US20160122420A1/en not_active Abandoned
- 2014-06-05 CA CA2914555A patent/CA2914555A1/en not_active Abandoned
- 2014-06-05 JP JP2016517683A patent/JP2016528176A/ja active Pending
- 2014-06-05 EP EP14733677.0A patent/EP3004173B1/en not_active Not-in-force
- 2014-06-05 WO PCT/GB2014/051739 patent/WO2014195713A1/en not_active Ceased
- 2014-06-05 CN CN201480041470.0A patent/CN105431457A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saif Linda | Vaccines for COVID-19: perspectives, prospects, and challenges based on candidate SARS, MERS, and animal coronavirus vaccines | |
| Zhou et al. | Prospects for a MERS-CoV spike vaccine | |
| JP2016528176A5 (cg-RX-API-DMAC7.html) | ||
| Christensen et al. | Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory | |
| Plotkin et al. | The development of vaccines: how the past led to the future | |
| JP6774149B2 (ja) | エンテロウイルス感染に対する免疫原としてのウイルス粒子およびその生産 | |
| Ibanez et al. | M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A | |
| JP2011521662A5 (cg-RX-API-DMAC7.html) | ||
| JP2016505635A5 (cg-RX-API-DMAC7.html) | ||
| WO2014018858A3 (en) | Multimeric fusion protein vaccine and immunotherapeutic | |
| JP2018536393A5 (cg-RX-API-DMAC7.html) | ||
| JP2012525128A5 (cg-RX-API-DMAC7.html) | ||
| JP2017507117A5 (cg-RX-API-DMAC7.html) | ||
| JP2011519869A5 (cg-RX-API-DMAC7.html) | ||
| JP2015524422A5 (cg-RX-API-DMAC7.html) | ||
| Reese et al. | A novel lactococcal vaccine expressing a peptide from the M2 antigen of H5N2 highly pathogenic avian influenza A virus prolongs survival of vaccinated chickens | |
| Fang et al. | Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies | |
| JP2017526689A5 (cg-RX-API-DMAC7.html) | ||
| JP2018500878A5 (cg-RX-API-DMAC7.html) | ||
| JP2017511140A5 (cg-RX-API-DMAC7.html) | ||
| JP2018517419A5 (cg-RX-API-DMAC7.html) | ||
| RU2018101722A (ru) | Днк-вакцина, нацеленная на vegfr-2, для комбинированной терапии | |
| JP2015529677A5 (cg-RX-API-DMAC7.html) | ||
| JP2013518563A5 (cg-RX-API-DMAC7.html) | ||
| JP2014502143A5 (cg-RX-API-DMAC7.html) |